Skip to main content
SpringerLink
Log in

Serious adverse events with tofacitinib versus TNF inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Seo GH, et al. The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database Journal of Korean Medical Science 37: e123, No. 16, 25 Apr 2022. Available from: URL: http://doi.org/10.3346/jkms.2022.37.e123

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serious adverse events with tofacitinib versus TNF inhibitors. Reactions Weekly 1905, 12 (2022). https://doi.org/10.1007/s40278-022-14402-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-14402-6

Search

Navigation